Michael McElhaugh
Interim President and CEO
CEO
COO
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arbutus Biopharma Corp (ABUS) | Former Interim President and Chief Executive Officer | $109,658 | $3,578,150 |
| 2024 | Arbutus Biopharma Corp (ABUS) | Former Interim President and Chief Executive Officer | $642,500 | $2,110,083 |
| 2023 | Arbutus Biopharma Corp (ABUS) | Former Interim President and Chief Executive Officer | $483,000 | $1,620,485 |
| 2022 | Arbutus Biopharma Corp (ABUS) | Current Interim President and Chief Executive Officer | $448,750 | $1,315,235 |
| 2021 | Arbutus Biopharma Corp (ABUS) | COO | — | — |
| 2020 | Arbutus Biopharma Corp (ABUS) | — | $415,000 | $1,087,791 |
Earnings-call appearances
-
Arbutus Biopharma Corp Q2 FY2024 Earnings Call2024-08-01
Arbutus Biopharma Corp (ABUS)
-
Arbutus Biopharma Corp Q4 FY2023 Earnings Call2024-02-29
Arbutus Biopharma Corp (ABUS)
-
Arbutus Biopharma Corp Q4 FY2022 Earnings Call2023-01-05
Arbutus Biopharma Corp (ABUS)